References
- Oddens BJ, Lehert P. Determinants of contraceptive use among women of reproductive age in Great Britain and Germany. I: Demographic factors. J Biosoc Sci 1997;29:415–435.
- Skouby SO. Contraceptive use and behavior in the 21st century: A comprehensive study across five European countries. Eur J Contracept Reprod Health Care 2004;9:57–68.
- Spinelli A, Talamanca IF, Lauria L. Patterns of contraceptive use in 5 European countries. European Study Group on Infertility and Subfecundity. Am J Public Health 2000;90:1403–1408.
- Cibula D. Women's contraceptive practices and sexual behaviour in Europe. Eur J Contracept Reprod Health Care 2008;13:362–75.
- Oddens BJ. Determinants of contraceptive use among women of reproductive age in Great Britain and Germany. II: Psychological factors. J Biosoc Sci 1997;29:437–470.
- Serbanescu F, Goldberg H, Morris L. Reproductive health in the transition countries of Europe. In Macura M, MacDonald A, Haug W, eds. The new demographic regime: Population challenges and policy responses. Geneva: United Nations, 2005:177–198.
- Batar I. State-of-the-art of intrauterine contraception. Eur J Contracept Reprod Health Care 2006;11:262–269.
- Inki P. Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 2007;75:S161–s166.
- Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56–72.
- Jensen JT. Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: An overview. Obstet Gynecol Surv 2005;60:604–612.
- Kriplani A, Singh BM, Lal S, et al Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynaecol Obstet 2007;97:190–194.
- Vercellini P, Vigano P, Somigliana E. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis. Curr Opin Obstet Gynecol 2005;17:359–365.
- Haimovich S. Profile of long-acting reversible contraception users in Europe. Eur J Contracept Reprod Health Care 2009;14:187–195.
- Prager S, Darney PD. The levonorgestrel intrauterine system in nulliparous women. Contraception 2007;75:S12–s15.
- Suhonen S, Haukkamaa M, Jakobsson T, et al Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study. Contraception 2004;69:407–412.
- ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol 2007;110:1493–1495.
- Belhadj H, Sivin I, Diaz S, et al Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 1986;34:261–267.
- Sivin I, Stern J, Diaz S, et al Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Am J Obstet Gynecol 1992;166:1208–1213.